Skip to main content
Verified Statutory Healthcare Resource — Indian Pharmacopoeia (IP) / CDSCO / PMBJP Jan Aushadhi Standards
Lab Tests & Diagnostics 5 min read • Last Updated: September 2026

Widal Test for Typhoid Fever: O and H Titres, False Positives & Accurate Testing

Clinical review of the Widal Test for Typhoid (Enteric Fever): S. typhi O and H antibody titres, baseline titers in India, high false positive rates,...

Statutory Medical Disclaimer & Emergency Safety Notice The pharmacological and therapeutic data presented in this educational guide is synthesized exclusively for public health literacy, academic reference, and educational purposes in conformity with the Indian Pharmacopoeia (IP 2022) and guidelines established by the Central Drugs Standard Control Organisation (CDSCO). This content does not constitute medical diagnosis, formal physician opinion, or individualized therapeutic instruction. Under the Drugs and Cosmetics Act, 1940 and the National Medical Commission (Professional Conduct) Regulations, Schedule H, H1, and X pharmaceutical formulations must be prescribed and monitored by a registered medical practitioner (RMP). Patients must not initiate, alter, or terminate any therapeutic drug regimen without formal clinical evaluation by their treating physician or a licensed healthcare professional. For acute medical emergencies, dial 112 / 108 (India) immediately.
🩺 Quick Clinical Answer

The Widal slide/tube agglutination test detects antibodies against Salmonella enterica serotype Typhi antigens: somatic 'O' antigen (indicates active acute infection if titre >1:160) and flagellar 'H' antigen (indicates past infection or immunization if titre >1:160). However, the Widal test has high false-positive rates in India due to endemic baseline immunity; blood culture drawn in the first week of fever is the gold standard.

1. The Anatomy of 'O' and 'H' Titres

The somatic 'O' antigen appears early (Day 7-10 of fever) and disappears quickly, representing acute infection. The flagellar 'H' antigen rises later and persists for months or years, representing past exposure or vaccination.

2. The Widespread False-Positive Dilemma in India

Because Salmonella exposure is common in India, many healthy individuals carry baseline titers of 1:80. A single positive Widal slide test during the first 3 days of fever is unreliable; diagnosing typhoid requires demonstrating a four-fold rise in antibody titers between acute and convalescent sera 7 days apart.

3. The True Gold Standard: Blood Culture & Typhidot

In the first week of fever, Blood Culture has an 80% diagnostic sensitivity and provides antibiotic susceptibility testing. Typhidot tests detect IgM antibodies against Salmonella 50kD outer membrane protein, offering higher specificity.

PMBJP Jan Aushadhi Price Transparency

Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison

Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.

Brand Name Leading Manufacturer Active Salt Formulation (IP) Branded MRP Jan Aushadhi Price Savings %
Augmentin 625 Duo GlaxoSmithKline Pharmaceuticals Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP ₹220.00 ₹58.00 74%
Dolo 650 Micro Labs Ltd Paracetamol (Acetaminophen) 650mg IP ₹34.00 ₹5.50 84%
Pantocid 40 Sun Pharmaceutical Industries Pantoprazole Sodium 40mg IP (Gastro-resistant) ₹155.00 ₹8.00 95%
Azithral 500 Alembic Pharmaceuticals Azithromycin Dihydrate 500mg IP ₹132.00 ₹24.00 82%
Glycomet 500 USV Private Limited Metformin Hydrochloride 500mg IP ₹24.00 ₹4.50 81%
Shelcal 500 Torrent Pharmaceuticals Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP ₹134.00 ₹16.00 88%
Telma 40 Glenmark Pharmaceuticals Telmisartan 40mg IP ₹92.00 ₹7.50 92%
Montair-LC Cipla Ltd Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP ₹210.00 ₹18.00 91%
Combined 8-Drug Essential Therapy Basket Total: ₹1,001.00 ₹141.00 85.9% Net Savings
Additional high-volume Indian medicines bioequivalent generic savings: Atorva 10 (Atorvastatin 10mg: Branded ₹110.00 vs Jan Aushadhi ₹12.00, 89% savings), Allegra 120 (Fexofenadine 120mg: Branded ₹215.00 vs Jan Aushadhi ₹32.00, 85% savings). Official Portal: PMBJP National Formulary (janaushadhi.gov.in) →

Frequently Asked Questions (Clinical & Regulatory)

Q1: Can taking antibiotics before a Widal test alter the results?

Antibiotics suppress the antibody response and inhibit bacterial recovery in blood cultures, making test interpretation difficult.

Q2: What symptoms confirm typhoid besides the lab report?

Step-ladder rising fever, coated white tongue, relative bradycardia (slow pulse despite high fever), dry cough, and abdominal tenderness.

Q3: Which routine diagnostic blood tests strictly require 10 to 12 hours of overnight fasting?

Fasting Blood Glucose (FBG), complete Lipid Profile (Total Cholesterol, Triglycerides, HDL, LDL), and Fasting Serum Insulin require 10–12 hours of water-only fasting to eliminate postprandial dietary chylomicrons and glycemic excursions from biasing baseline values.

Q4: What is the clinical difference between Fasting Blood Sugar and HbA1c tests?

Fasting blood sugar reflects glucose concentration at a single momentary blood draw, whereas HbA1c quantifies the percentage of hemoglobin glycated over the erythrocyte lifecycle, reflecting mean glycemic exposure across the preceding 90 to 120 days.

Q5: How do reference ranges on automated diagnostic lab reports vary between laboratories?

Reference intervals reflect the central 95% distribution of a validated healthy reference cohort tested on specific analyzer architectures (e.g., Roche Cobas, Abbott Architect). Results must always be interpreted against the specific testing laboratory's reported reference range.

MediMatch AI Clinical Pharmacology Review Board
Clinically reviewed by Dr. Vikram Anand, MBBS, MD (Clinical Pharmacology), Dr. Aditi Sharma, MD Pharmacology & Dr. Rajesh Nair, PharmD, RPh

This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.

Official Statutory References: Indian Pharmacopoeia Commission (ipc.gov.in) → PMBJP Jan Aushadhi Portal (janaushadhi.gov.in) → CDSCO Health & Family Welfare (cdsco.gov.in) →
Digital Personal Data Protection (DPDP) Act, 2023 Statutory Health Privacy Disclosure

Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.